H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

H. B. Fuller Company

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kymera Therapeutics (KYMR – Research Report), Fulcru...

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Fulcrum Therapeutics (FULC) and Novan (NOVN)

In a report released today, from Roth MKM reiterated a Buy rating on Fulcrum Therapeutics, with a price target of $15.00. In addition to Roth MKM, ...

Fulcrum Therapeutics (FULC) Receives a Buy from Roth MKM

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY – Research Report), Fulcrum Therapeut...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fulcrum Therapeutics (FULC) and Arcellx Inc (ACLX)

In a report released on December 6, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Fulcrum Therapeutics, with a price target of $...

Cantor Fitzgerald Remains a Buy on Fulcrum Therapeutics (FULC)

In a report released today, James Condulis from Stifel Nicolaus maintained a Buy rating on Fulcrum Therapeutics, with a price target of $20.00. Con...

Stifel Nicolaus Remains a Buy on Fulcrum Therapeutics (FULC)

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Fulcrum Therapeutics today and set a price target of $15.00. Biegler covers the Heal...

Fulcrum Therapeutics (FULC) Receives a Buy from Oppenheimer

Fulcrum Therapeutics ( ($FULC) ) just unveiled an announcement. On December 6, 2025, Fulcrum Therapeutics announced positive initial results from t...

Fulcrum Therapeutics Reports Positive Phase 1b Trial Results

Truist Financial analyst maintained a Buy rating on Fulcrum Therapeutics yesterday. The company’s shares closed yesterday at $9.06. In addition to ...

Truist Financial Keeps Their Buy Rating on Fulcrum Therapeutics (FULC)

Fulcrum Lithium Ltd. ( ($AU:FUL) ) has issued an update. Fulcrum Lithium Ltd. has announced a presentation at their Annual General Meeting, schedul...

Fulcrum Lithium Ltd. Annual General Meeting Presentation

An update from Fulcrum Lithium Ltd. ( ($AU:FUL) ) is now available. Fulcrum Lithium Ltd. has announced the initiation of the Dry Canyon lithium cla...

Fulcrum Lithium Launches New Exploration Project in Nevada

Fulton Financial ( ($FULT) ) just unveiled an announcement. On November 24, 2025, Fulton Financial Corporation announced a merger agreement with Bl...

Fulton Financial Announces Merger with Blue Foundry

Fulton Financial ( ($FULT) ) just unveiled an update. On November 24, 2025, Fulton Financial Corporation announced a merger agreement to acquire Bl...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FUL	$60.19	-0.31%	269.17K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FUL	$60.19	-0.3%	269.17K
3
4
5
6

FUL

FUL

Get H. B. Fuller Company Data in Excel

Get H. B. Fuller Company Data in Excel